"0074-2625-80" National Drug Code (NDC)

NDC Code	0074-2625-80
Package Description	84 TABLET, FILM COATED in 1 BOTTLE (0074-2625-80)
Product NDC	0074-2625
Product Type Name	HUMAN PRESCRIPTION DRUG
Proprietary Name	Mavyret
Non-Proprietary Name	Glecaprevir And Pibrentasvir
Dosage Form	TABLET, FILM COATED
Usage	ORAL
Start Marketing Date	20170803
Marketing Category Name	NDA
Application Number	NDA209394
Manufacturer	AbbVie Inc.
Substance Name	GLECAPREVIR; PIBRENTASVIR
Strength	100; 40
Strength Unit	mg/1; mg/1
Pharmacy Classes	Breast Cancer Resistance Protein Inhibitors [MoA], Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], HCV NS3/4A Protease Inhibitors [MoA], Hepatitis C Virus NS3/4A Protease Inhibitor [EPC], Hepatitis C Virus NS5A Inhibitor [EPC], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], UGT1A1 Inhibitors [MoA], UGT1A1 Inhibitors [MoA]